Krammer, F., Srivastava, K., Alshammary, H., Amoako, A.A., Awawda, M.H., Beach, K.F., Bermúdez-González, M.C., Bielak, D.A., Carreño, J.M., Chernet, R.L., Eaker, L.Q., Ferreri, E.D., Floda, D.L., Gleason, C.R., Hamburger, J.Z., Jiang, K., Kleiner, G., Jurczyszak, D., Matthews, J.C., Mendez, W.A., Nabeel, I., Mulder, L.C.F., Raskin, A.J., Russo, K.T., Salimbangon, A.T., Saksena, M., Shin, A.S., Singh, G., Sominsky, L.A., Stadlbauer, D., Wajnberg, A. and Simon, V. (2021) Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine. The New England Journal of Medicine, 384, 1372-1374.
https://doi.org/10.1056/NEJMc2101667

has been cited by the following article:

• TITLE: Reasons of Vaccine Hesitancy among Pakistanis with Available COVID-19 Vaccine: The Next Challenge in the Fight against COVID-19

  AUTHORS: Wajiha Rizwan, Muhammad Nasir Rana, Mulazim Hussain Bukhari, Asma Mushtaq, Masood Sadiq

  KEYWORDS: COVID-19, Vaccine Hesitancy, Vaccine Side Effects, Vaccine and Propaganda, Herd Immunity

  JOURNAL NAME: Natural Science, Vol.13 No.6, June 15, 2021

  ABSTRACT: The government of Pakistan started vaccination campaign for the frontline healthcare pro-viders, as they are more likely to be exposed to COVID-19 patients. In the next step, it ex-tended the free vaccination campaign to include people above 60 and 50 years of age re-spectively. The drive is now open to all citizens >18 years of age. There is a significant re-luctance to get vaccinated even though the government has provided it free of cost. The project uses self-reporting method to assess reasons of vaccine hesitancy among Pakistanis and possible solutions to overcome this problem. Concern for serious side effects was the most common issue 154 (48.42%) reported among all groups of people, including the healthcare workers. The major sources of COVID-19 related information were television 117 (36.8%) and healthcare professionals 105 (33%). The participants reported that they can be convinced to get vaccinated if more published data related to vaccine efficacy and safety is available 118 (37.1%), they observe no side effect among vaccine recipients 90 (28.3%) or higher government officials get the same vaccine 39 (12.3%). Vigorous analysis and publication of data generated is paramount to increase the percentage of people being vaccinated. The healthcare professionals should share evidence-based knowledge related to vaccine efficacy and safety through television and social media to increase acceptance rates and hence, decrease mortality and morbidity from COVID-19 in Pakistan.